Target
Mu-type opioid receptor
Ligand
BDBM464589
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
37.4±n/a nM
Citation
 Kuehnert, SKoenigs, RMKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, W 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10793556 Publication Date 10/6/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM464589
Synonyms:
CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-3-(2-methylsulfonyl-ethyl)-8-phenyl- 1,3-diazaspiro[4.5]decan-2-one | US10793556, Example SC_4009
Type:
Small organic molecule
Emp. Form.:
C24H37N3O3S
Mol. Mass.:
447.634
SMILES:
CN(C)[C@]1(CC[C@]2(CN(CCS(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:3.2,6.17,(11.74,2.89,;10.26,3.29,;9.86,4.77,;9.17,2.2,;8.4,.86,;6.86,.86,;6.09,2.2,;5.18,3.44,;3.72,2.97,;2.63,4.06,;1.14,3.66,;.05,4.75,;.45,6.23,;-1.44,4.35,;-.35,3.26,;3.72,1.43,;2.47,.52,;5.18,.95,;5.66,-.51,;4.63,-1.66,;3.14,-2.06,;3.54,-3.54,;5.03,-3.15,;6.86,3.53,;8.4,3.53,;10.26,1.11,;9.86,-.38,;10.95,-1.47,;12.43,-1.07,;12.83,.42,;11.74,1.51,)|
Structure:
Search PDB for entries with ligand similarity: